Method of treating heparin-induced thrombocytopenia
AssigneeEli Lilly and Company
InventorsCharles Jack Fisher, Sau-Chi Betty Yan
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treatment of heparin-induced thrombocytopenia (HIT) with protein C. The claimed invention provides a needed therapy for a potentially serious and debilitating disorder while avoiding complications such as bleeding tendency, toxicity and general side effects of currently available anticoagulant agents.
Claims10
A method of treating a patient suffering from heparin-induced thrombocytopenia (HIT) which comprises, administering to said patient a pharmaceutically effective amount of protein C.
A method of treating heparin-induced thrombocytopenia in a patient in need thereof, which comprises administering to said patient a pharmaceutically effective amount of activated protein C such that an activated protein C plasma level of about 2 ng/ml to about 300 ng/ml is achieved.
Dependencies are inferred from the claim text.